Integrated BioPharma (INBP) Short Interest Ratio & Short Volume $0.32 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Integrated BioPharma Short Interest DataIntegrated BioPharma (INBP) has a short interest of 200 shares. This marks a -60.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 11,067 shares to cover all short positions.Current Short Interest200 sharesPrevious Short Interest500 sharesChange Vs. Previous Month-60.00%Dollar Volume Sold Short$50.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares30,100,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume2,000 sharesAverage Trading Volume11,067 sharesToday's Volume Vs. Average18% Short Selling Integrated BioPharma? Sign up to receive the latest short interest report for Integrated BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINBP Short Interest Over TimeINBP Days to Cover Over TimeINBP Percentage of Float Shorted Over Time Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Integrated BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024200 shares $50.00 -60.0%N/A0 $0.25 9/30/2024500 shares $117.20 -28.6%N/A0.1 $0.23 9/15/2024700 shares $160.93 +600.0%N/A0 $0.23 8/31/2024100 shares $19.00 No ChangeN/A0 $0.19 8/15/2024100 shares $16.38 No ChangeN/A0 $0.16 7/31/2024100 shares $20.00 No ChangeN/A0.5 $0.20 Get the Latest News and Ratings for INBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024100 shares $20.00 No ChangeN/A0.1 $0.20 6/30/2024100 shares $21.00 No ChangeN/A0.5 $0.21 6/15/2024100 shares $22.32 No ChangeN/A0.4 $0.22 5/31/2024100 shares $25.00 No ChangeN/A0.1 $0.25 5/15/2024100 shares $22.00 No ChangeN/A0 $0.22 4/30/2024100 shares $21.00 No ChangeN/A0.1 $0.21 4/15/2024100 shares $21.50 No ChangeN/A0 $0.22 11/15/20231,000 shares $270.00 -70.6%N/A0.1 $0.27 10/31/20233,400 shares $822.12 -15.0%N/A0.1 $0.24 10/15/20234,000 shares $1,060.00 +700.0%N/A0.7 $0.27 9/30/2023500 shares $140.00 -70.6%N/A0 $0.28 9/15/20231,700 shares $484.50 No ChangeN/A1.7 $0.29 8/31/20231,700 shares $477.70 No ChangeN/A1.7 $0.28 8/15/20231,700 shares $510.15 +240.0%N/A8.5 $0.30 7/31/2023500 shares $165.20 No ChangeN/A0 $0.33 7/15/2023500 shares $167.40 No ChangeN/A0 $0.33 6/30/2023500 shares $165.61 No ChangeN/A0.3 $0.33 6/15/2023500 shares $165.00 -37.5%N/A0.4 $0.33 5/31/2023800 shares $272.00 +60.0%N/A0.3 $0.34 5/15/2023500 shares $190.00 No ChangeN/A0.1 $0.38 4/30/2023500 shares $190.00 No ChangeN/A0.2 $0.38 4/15/2023500 shares $189.88 -80.8%N/A0.1 $0.38 3/31/20232,600 shares $995.80 -42.2%N/A0.7 $0.38 3/15/20234,500 shares $1,755.00 -25.0%N/A2.5 $0.39 2/28/20236,000 shares $2,640.00 +62.2%N/A1.4 $0.44 2/15/20233,700 shares $1,457.80 +2.8%N/A0.3 $0.39 1/31/20233,600 shares $1,260.00 +2.9%N/A1.2 $0.35 1/15/20233,500 shares $1,540.00 No ChangeN/A11.7 $0.44 12/30/20223,500 shares $1,461.25 No ChangeN/A5.8 $0.42 12/15/20223,500 shares $1,348.20 +133.3%N/A0.8 $0.39 11/30/20221,500 shares $574.50 +650.0%N/A0.3 $0.38 11/15/2022200 shares $86.00 No ChangeN/A0.1 $0.43 9/15/20221,300 shares $662.35 No ChangeN/A0.1 $0.51 6/15/20221,800 shares $1,083.60 +125.0%N/A0.2 $0.60Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 5/31/2022800 shares $647.60 -55.6%N/A0.1 $0.81 5/15/20221,800 shares $1,439.10 -88.5%N/A0.1 $0.80 4/30/202215,600 shares $12,324.00 +766.7%N/A0.7 $0.79 4/15/20221,800 shares $1,440.00 +1,700.0%N/A0.1 $0.80 3/31/2022100 shares $78.95 -97.2%N/A0 $0.79 3/15/20223,600 shares $3,024.00 +28.6%N/A0.3 $0.84 2/28/20222,800 shares $2,658.60 -42.9%N/A0.2 $0.95 2/15/20224,900 shares $4,753.00 No ChangeN/A0.1 $0.97 1/15/20223,300 shares $3,531.00 +22.2%N/A0.2 $1.07 12/31/20212,700 shares $2,808.00 +17.4%N/A0.1 $1.04 12/15/20212,300 shares $2,252.85 -54.0%N/A0.1 $0.98 11/30/20215,000 shares $4,947.50 +4,900.0%N/A0.1 $0.99 11/15/2021100 shares $92.50 -95.2%N/A0 $0.93 10/29/20212,100 shares $2,226.00 +600.0%N/A0.4 $1.06 10/15/2021300 shares $327.00 +50.0%N/A0 $1.09 9/30/2021200 shares $210.00 -50.0%N/A0 $1.05 9/15/2021400 shares $448.00 +33.3%N/A0 $1.12 8/31/2021300 shares $282.00 -90.3%N/A0 $0.94 8/13/20213,100 shares $2,974.45 +3,000.0%N/A0.1 $0.96 7/30/2021100 shares $104.00 -94.4%N/A0 $1.04 7/15/20211,800 shares $1,931.40 +50.0%N/A0.1 $1.07 6/30/20211,200 shares $1,320.00 -67.6%N/A0 $1.10 6/15/20213,700 shares $4,366.00 +516.7%N/A0.1 $1.18 5/28/2021600 shares $732.00 +500.0%N/A0 $1.22 5/14/2021100 shares $118.00 -75.0%N/A0 $1.18 4/30/2021400 shares $420.00 +100.0%N/A0 $1.05 4/15/2021200 shares $218.00 +100.0%N/A0 $1.09 3/31/2021100 shares $105.00 -91.7%N/A0 $1.05 3/15/20211,200 shares $1,152.00 -14.3%N/A0.1 $0.96 2/26/20211,400 shares $1,358.00 -70.8%N/A0 $0.97 2/12/20214,800 shares $4,608.00 -57.1%N/A0.1 $0.96 1/29/202111,200 shares $10,416.00 +1,020.0%N/A0.4 $0.93 1/15/202111,200 shares $9,072.00 +64.7%N/A0.8 $0.81 12/31/20202,500 shares $1,762.50 -77.7%N/A0.1 $0.71 12/15/202011,200 shares $8,904.00 +64.7%N/A0.8 $0.80 11/30/20206,800 shares $5,508.00 +3,300.0%N/A0.1 $0.81 11/15/2020200 shares $120.00 No ChangeN/A0.1 $0.60 9/30/2020200 shares $94.00 +100.0%N/A0 $0.47 9/15/2020100 shares $44.00 No ChangeN/A0 $0.44 8/31/2020100 shares $42.00 No ChangeN/A0 $0.42 8/14/2020100 shares $42.00 No ChangeN/A0.1 $0.42 7/15/20204,500 shares $2,128.50 +4,400.0%N/A1 $0.47 6/30/2020100 shares $45.00 -50.0%N/A0 $0.45 6/15/2020200 shares $96.00 +100.0%N/A0 $0.48 5/29/2020100 shares $48.50 -96.0%N/A0 $0.49 5/15/20202,500 shares $1,250.00 +47.1%N/A0.2 $0.50 4/30/20201,700 shares $714.00 No ChangeN/A0.1 $0.42 3/13/2020200 shares $69.96 No ChangeN/A0 $0.35 2/28/2020200 shares $73.00 No ChangeN/A0 $0.37 12/31/2019100 shares $24.30 No ChangeN/A0 $0.24Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW INBP Short Interest - Frequently Asked Questions What is Integrated BioPharma's current short interest? Short interest is the volume of Integrated BioPharma shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 200 shares of INBP short. Learn More on Integrated BioPharma's current short interest. Is Integrated BioPharma's short interest increasing or decreasing? Integrated BioPharma saw a drop in short interest during the month of October. As of October 15th, there was short interest totaling 200 shares, a drop of 60.0% from the previous total of 500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Integrated BioPharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Integrated BioPharma: VolitionRx Limited (0.64%), Marker Therapeutics, Inc. (0.95%), Lexaria Bioscience Corp. (1.71%), Elevation Oncology, Inc. (11.90%), Avalon GloboCare Corp. (3.49%), Lantern Pharma Inc. (2.21%), Lumos Pharma, Inc. (5.41%), Surrozen, Inc. (1.90%), Daré Bioscience, Inc. (0.53%), BioLineRx Ltd. (0.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Integrated BioPharma stock? Short selling INBP is an investing strategy that aims to generate trading profit from Integrated BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Integrated BioPharma? A short squeeze for Integrated BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INBP, which in turn drives the price of the stock up even further. How often is Integrated BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBP, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies VolitionRx Short Squeeze Marker Therapeutics Short Squeeze Lexaria Bioscience Short Squeeze Elevation Oncology Short Squeeze Avalon GloboCare Short Squeeze Lantern Pharma Short Squeeze Lumos Pharma Short Squeeze Surrozen Short Squeeze Daré Bioscience Short Squeeze BioLineRx Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:INBP) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integrated BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integrated BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.